Myasthenia Gravis

Diagnosis and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Neurology

Clinical Guidelines

NICE Technology Appraisal Guidance [TA1069]: Efgartigimod for treating antibody-positive generalised myasthenia gravis
National
NICE Technology Appraisal Guidance [TA940]: Eculizumab for treating refractory myasthenia gravis
National
Suspected neurological conditions: recognition and referral (NICE guideline NG127)
National
Guideline for the management of myasthenic syndromes
Local
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
Local
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
Local
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
Local
The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome
Local